← Back to headlines
FDA Requests More Data from Eli Lilly for Obesity Drug
Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has requested additional clinical data regarding its experimental obesity pill, potentially delaying its approval.
19 Apr, 05:03 — 19 Apr, 05:03
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Manila Archdiocese Calls for Used Cooking Oil Collection for Biodiesel Amid Fuel Crisis
just now
Samar Town Warns Residents Against Alleged Maharlika Investment Fraud
just now
Ireland's Affordable Rent Scheme Reduces Prices, Faces Improvement Challenges
11m ago